๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

MYC, MAX, and Small Cell Lung Cancer

โœ Scribed by Rudin, C. M.; Poirier, J. T.

Book ID
121529239
Publisher
American Association for Cancer Research
Year
2014
Tongue
English
Weight
337 KB
Volume
4
Category
Article
ISSN
2159-8274

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Adenovirus-mediated gene therapy specifi
Adenovirus-mediated gene therapy specific for small cell lung cancer cells using a Myc-Max binding motif
โœ Kazumi Nishino; Tadashi Osaki; Toru Kumagai; Takashi Kijima; Isao Tachibana; Hir ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 127 KB ๐Ÿ‘ 2 views

Recent clinical trials of gene therapy for patients with thoracic cancers have shown that these treatments were well tolerated with minimal side effects and that we need to further enhance specificity as well as efficiency of gene transfer to target cancer cells. We previously reported that mycovere

Oligopeptides impairing the Myc-Max hete
Oligopeptides impairing the Myc-Max heterodimerization inhibit lung cancer cell proliferation by reducing Myc transcriptional activity
โœ Igea D'Agnano; Alessandra Valentini; Giuliana Gatti; Alberto Chersi; Armando Fel ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 340 KB

## Abstract Deregulated __CMYC__ gene causes cell transformation and is often correlated with tumor progression and a worse clinical outcome of cancer patients. The transcription factor Myc functions by heterodimerizing with its partner, Max. As a strategy to inhibit Myc activity, we have synthesiz